Vimarsana
Biggest News Aggregation in the World

Page 28 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Innovation in Technology Sparks Growth in Consumer Genomics: North America Leads While Asia-Pacific Gears Up for Rapid Expansion - Vimarsana News

Innovation in Technology Sparks Growth in Consumer Genomics: North America Leads While Asia-Pacific Gears Up for Rapid Expansion

/PRNewswire/ -- The "Consumer Genomics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global consumer genomics...

Oncology Molecular Diagnostics Market to grow by USD 2.980 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio - Vimarsana News

Oncology Molecular Diagnostics Market to grow by USD 2.980 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio

/PRNewswire/ -- The oncology molecular diagnostics market size is expected to grow by USD 2.98 billion from 2022 to 2027. In addition, the momentum of the...

Women's health diagnostics market to grow by USD 13.35 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio - Vimarsana News

Women's health diagnostics market to grow by USD 13.35 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio

/PRNewswire/ -- The women's health diagnostics market size is expected to grow by USD 13.35 billion from 2022 to 2027. In addition, the momentum of the market...

Autoimmune Disease Testing Market: Unlocking Opportunities on the Path to US$15.75 Billion by 2033 - Vimarsana News

Autoimmune Disease Testing Market: Unlocking Opportunities on the Path to US$15.75 Billion by 2033

The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033.The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, an...

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Brokerages - Vimarsana News

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy […]

Source: wkrb13.com